‘Too Big to Ban’ WuXi AppTec Gains 100% on GLP-1 Chokehold Bloomberg - WuXi too big to ban

@pep_researcher For sure, they have amazing R&D, but its the evil empire. They have done the impact analysis on peptides and determined what to bring to market that doesn't impact other medications, profit centers. They are slow rolling Reta; it's obvious. While they do the slow roll they are creating market buzz, and trying to drive up black market prices. Its all strategy.

@Randy ILS COA!

@Stevepep said: @montemontemayor love it!! I now label how much bac I used so when I titrate I remember Prob a good idea too. I have that in a separate spreadsheet

Check out Peptide Instructible by Peptide Critic https://www.youtube.com/@PeptideInstructible

Confirmed as a false positive.

@Stevepep said: she is one of few people I can tolerate on YouTube. It’s a cess pool otherwise ESPECIALLY that weirdo with the toy mouse, really hard to concentrate on what he is saying when he keeps distracting you with them sexy, model, hands...

@Randy Ha ha, like Wayne Gretzky used to say, if you don't take the shot, you can't score.

@Randy entries for engagement sounds great!!

@Nuncles And most I've met love to dance!

I thought it was great and pretty full of good info!

@MyB thanks that great advice i appreciate that

@jamestucci said in Peptide Critic Community Guidelines: Hi, James here! Interested in peptide reviews and user reviews! Hi James, There is a vendor review section, good info there. The search feature is helpful as well, you can enter the name of pep or Vendor name and retrieve by title or posts, oftentimes I found using posts for pep name I get better/more results

@mikepinkerton There's a doctor speaking about peppers quite candidly. He said all these bans and crackdowns don't work, as history has shown repeatedly. People always find ways to get what they want and their power in numbers outsmart limited resources of regulators. https://youtu.be/ZPHfz-3pkQ0?si=5Vzvp90dK6x0PjYq As an observation: after FDA shutdown two 503Bs, more telehealths and other 503Bs popped up with compounded tirzepatide. After they sent letters to some RUO vendors, a dozen more new ones have popped up. Constant ads on Insta and FB.

@justalittleprick said in FDA warning letters: I read the letter for one of the vendors and it mentioned BAC water, which is disappointing and signals the direction they are going to go if/when they crack down. This is largely how the FDA proves intent for human use. Vendors that sell anything that facilitates human use breaks the "for research use only" veil. The FDAs logic is that if you are selling peptides with everything you need to also inject those peptides, like BAC, syringes, and alcohol pads, you're not really selling them for research use and are fully aware your customers are injecting them.

I got an email from the telehealth provider that I had been buying Tirzepatide from for several months. They are expanding to start selling NAD+ and Sermorelin, and also sent out a survey about health goals and other peptides I might be interested in buying. I think it is interesting given the context of crackdowns on compounded GLP-1’s, price drops, potential actions on peptides (for and against) etc. I interpret this as companies being willing to do whatever they can to find and exploit a market. I understand why they would want to start with NAD+ and Sermorelin, but it also seems a bit of an odd starting point. NAD+ gives you the immediate hit to draw people in, while sermorelin is more like, “Pay is $400/month and in 6 months you’ll feel a little bit better, maybe.”

I understand that. That was not my point... My point is if things are scattered, a lot of people will miss them. Then less people will be included to actually come participate because it is hard to find information. I see this with Car boards, bodybuilding boards, etc..

Thanks all! The one on ezpeptides must have ended when I tried it.